Patent · US Active

Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus

US8492347B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2008
Grant dateJul 23, 2013
Priority date
Expiry dateApr 10, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K7/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to D-amino acid peptides and their use in methods for the diagnosis and/or treatment of immune disorders such as systemic lupus erythematosus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.